First itraconazole resistant Aspergillus fumigatus clinical isolate harbouring a G54E substitution in Cyp51Ap in South America

Bader, 2013, cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany, Antimicrob Agents Chemother, 57, 3513, 10.1128/AAC.00167-13 Balajee, 2006, Phenotypic and genotypic identification of human pathogenic aspergilli, Future Microbiol, 1, 435, 10.2217/17460913.1.4.435 Balajee, 2009, Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network, J Clin Microbiol, 47, 3138, 10.1128/JCM.01070-09 Clinical and Laboratory Standards Institute, 2008 Dannaoui, 2001, Acquired itraconazole resistance in Aspergillus fumigatus, J Antimicrob Chemother, 47, 333, 10.1093/jac/47.3.333 Diaz-Guerra, 2003, A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus, Antimicrob Agents Chemother, 47, 1120, 10.1128/AAC.47.3.1120-1124.2003 Espinel-Ingroff, 2011, Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document), Antimicrob Agents Chemother, 55, 2855, 10.1128/AAC.01730-10 Espinel-Ingroff, 2013, 59 Hof, 2001, Critical annotations to the use of azole antifungals for plant protection, Antimicrob Agents Chemother, 45, 2987, 10.1128/AAC.45.11.2987-2990.2001 Howard, 2009, Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure, Emerg Infect Dis, 15, 1068, 10.3201/eid1507.090043 Mann, 2003, Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase, Antimicrob Agents Chemother, 47, 577, 10.1128/AAC.47.2.577-581.2003 Mellado, 2001, Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species, J Clin Microbiol, 39, 2431, 10.1128/JCM.39.7.2431-2438.2001 Mosquera, 2002, Azole cross-resistance in Aspergillus fumigatus, Antimicrob Agents Chemother, 46, 556, 10.1128/AAC.46.2.556-557.2002 Snelders, 2008, Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism, PLoS Med, 11, e219, 10.1371/journal.pmed.0050219 van der Linden, 2011, Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007–2009, Emerg Infect Dis, 17, 1846, 10.3201/eid1710.110226 Vermeulen, 2013, Azole resistance in Aspergillus fumigatus: a growing public health concern, Curr Opin Infect Dis, 26, 493, 10.1097/QCO.0000000000000005 Verweij, 2009, Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?, Lancet Infect Dis, 9, 789, 10.1016/S1473-3099(09)70265-8